- Oops!Something went wrong.Please try again later.
COVID-19 driving key products and companies within the biopharmaceutical industry in 2022
LONDON, May 31, 2022 (GLOBE NEWSWIRE) -- Pfizer is forecast to continue to be the leading company by sales into 2022 due to its command of the COVID-19 market. Comirnaty, Pfizer’s COVID-19 vaccine, continues to have the highest sales going into 2022 despite a downward trend.
The Future of Pharma market research report offered by GlobalData Plc provides sales and regulatory-based insights into this coming year covering individual products and key areas of focus. The report gives regulatory-based insights into future trends that may negatively impact segments of the industry. It provides sales-based long-term insights into key sections of the industry and how they will change from this year (2022) to five years (2027) into the future and what is driving them. The report also offers clinical insights on planned and pivotal clinical trials based on this upcoming year and their trends.
Key Pharma Market Highlights
Oncology remains the leading therapy area despite significant growth in other therapy areas.
COVID-19 continues to dominate the key trends within the biopharmaceutical industry in 2022.
Phase IV trials are dominated by COVID-19 vaccines alongside psychedelic therapies.
Biologic drugs solidify their lead over small molecules and are now primary engines of value creation for large-cap pharma companies.
The majority of 2022 clinical trials are in late-stage development.
Eli Lilly is forecast to become a leading top 10 company within five years due to significant sales growth.
Pharma Market Segmentation by Therapy Area
Central nervous system
Pharma Market Analysis, by Therapy Area
For more insights on key therapy areas, download a free report sample
Key Drugs in the Pharma Market
Pharma Market Analysis, by Drugs
For more insights on top drugs, download a free report sample
Leading Pharma Companies
Merck & Co
Johnson & Johnson
F.Hoffman-La Roche Ltd
Bristol-Myers Squibb Co
Novo Nordisk AS
Takeda Pharmaceutical Co Ltd
Boehringer Ingelheim International GmbH
Eli Lilly and Co
Pharma Market Analysis, by Companies
Pharma Market Overview
Key Therapy Areas
Oncology, Infectious Disease, Central Nervous System, Immunology, Metabolic Disorders, Cardiovascular, Respiratory, Hematological Disorders, Ophthalmology, and Gastrointestinal
Keytruda, Opdivo, Revlimid, Comirnaty, Humira, Eliquis, Spikevax, Eylea, Stelara, and Biktarvy
Pfizer, Merck & Co, Novartis AG, Johnson & Johnson, Abbvie, F.Hoffman-La Roche Ltd, Bristol-Myers Squibb Co, AstraZeneca Plc, Sanofi, GlaxoSmithKline Plc, Novo Nordisk AS, Takeda Pharmaceutical Co Ltd, Novavax Inc, Bayer AG, Boehringer Ingelheim International GmbH, Eli Lilly and Co
Pharma Market Report Scope
This 49-page report gives important, expert insight you won’t find in any other source. 21 figures throughout the report illustrate major points and trends in future pharmaceutical sales forecasts and company pipelines. This report is required reading for:
Investors that want to understand future trends impacting the biopharmaceutical industry as well as identify companies to invest in
Companies that are interested in entering the biopharmaceutical space and where best to focus on
Large pharma companies with investment groups or BD teams looking to see which companies are predicted to lead the industry in the near and far future
Small and medium pharma who want to focus their drug portfolio on future trends and are looking for partnership opportunities
Reasons to Buy
Year Ahead Opportunities – looking ahead in 2022 using sales and regulatory analyses to identify events and trends that may be opportunities.
Year Ahead Threats -looking ahead in 2022 using sales forecasts and clinical analyses to identify events and trends that may pose a threat.
Future opportunities – looking ahead 5 years into the future, using sales forecasts and analyses to identify the opportunities in 2027 that can be exploited.
Clinical trials – using clinical analyses to identify key areas within clinical trials that have begun or are planned for 2022.
What are the key therapy areas in the pharma market?
Oncology, infectious disease, central nervous system, immunology, metabolic disorders, cardiovascular, respiratory, hematological disorders, ophthalmology, and gastrointestinal are the key therapy areas in the pharmaceuticals market.
What are the key drugs in the pharma market?
Keytruda, Opdivo, Revlimid, Comirnaty, Humira, Eliquis, Spikevax, Eylea, Stelara, and Biktarvy are the key drugs in the pharmaceuticals market.
Which are the leading companies in the pharma market?
Some of the leading pharmaceuticals companies are Pfizer, Merck & Co, Novartis AG, Johnson & Johnson, Abbvie, F.Hoffman-La Roche Ltd, Bristol-Myers Squibb Co, AstraZeneca Plc, Sanofi, GlaxoSmithKline Plc, Novo Nordisk AS, Takeda Pharmaceutical Co Ltd, Novavax Inc, Bayer AG, Boehringer Ingelheim International GmbH, Eli Lilly and Co
South Africa Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement, and Competitive Landscape – Click here
Chronic Kidney Disease Epidemiology Analysis and Forecast, 2021-2031 – Click here
Thailand Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement, and Competitive Landscape – Click here
Renal Cell Carcinoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media, and Competitive Landscape – Click here
Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape – Click here
GlobalData is a leading provider of data, analytics, and insights on the world's largest industries. In an increasingly fast-moving, complex, and uncertain world, it has never been harder for organizations and decision makers to predict and navigate the future. This is why GlobalData's mission is to help our clients to decode the future and profit from faster, more informed decisions. As a leading information services company, thousands of clients rely on GlobalData for trusted, timely, and actionable intelligence. Our solutions are designed to provide a daily edge to professionals within corporations, financial institutions, professional services, and government agencies.
Head of PR EMEA
+44 (0)207 936 6400